ICD-10-CM Billable Code

J63.2

Berylliosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Berylliosis, also known as chronic beryllium disease, is a lung condition caused by exposure to beryllium, a lightweight metal used in various industrial applications. This condition involves an immune response that leads to inflammation and scarring of lung tissue. Recognizing the risk factors, symptoms, and medical approaches for berylliosis is essential for affected individuals and those working in related industries. This overview explains what berylliosis is, how it develops, common symptoms, how it is diagnosed, and the typical treatment options available.

Causes & Symptoms

Clinical Causes: Berylliosis results primarily from prolonged inhalation of dust or fumes containing beryllium particles. Jobs and environments associated with increased risk include: - Aerospace and aircraft manufacturing - Electronics and computer industries - Nuclear power plants - Dental and medical equipment manufacturing - Industrial grinding or machining of beryllium-containing materials - Handling beryllium or its compounds without proper protective measures

Key Symptoms: The symptoms of berylliosis can develop gradually and might include: - Persistent cough - Shortness of breath, especially during physical activity - Fatigue or weakness - Chest discomfort or pain - Mild fever - Unintentional weight loss - Night sweats - Fine crackles heard in the lungs during physical examination In some cases, symptoms may resemble those of other lung diseases, which can complicate diagnosis.

Diagnostic & Treatment

Diagnosis Path: Healthcare providers utilize a combination of methods to confirm berylliosis: - Medical history assessment, focusing on occupational exposure - Physical examination of the lungs - Chest X-rays to identify patterns of inflammation or scarring - Pulmonary function tests measuring lung capacity and airflow - Blood tests, including beryllium lymphocyte proliferation tests (BeLPT), to detect immune reactions to beryllium - Biopsy of lung tissue may also be performed in certain cases to observe granulomas or scarring directly Early detection is vital for managing the disease effectively.

Treatment Protocols: While there is no specific cure for berylliosis, treatments aim to reduce symptoms and prevent disease progression: - Corticosteroids, such as prednisone, are commonly used to decrease lung inflammation - Immunosuppressive drugs may be prescribed for severe cases - Supplemental oxygen therapy can assist with breathing difficulties - Pulmonary rehabilitation programs help improve quality of life - Avoidance of further beryllium exposure is critical Monitoring disease progression through regular medical check-ups is important for individuals with diagnosed berylliosis.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is J63.2 a billable ICD-10 code?
Yes, J63.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report J63.2?
Clinical documentation must specify the nature of Berylliosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

berylliosis